Clinical Report: Ferroptosis-Related Cellular Signatures in ESCC
Overview
This study identifies ferroptosis-related cellular signatures in esophageal squamous cell carcinoma (ESCC) that correlate with prognostic outcomes and treatment responses. A prognostic model based on four key genes was developed and validated.
Background
Esophageal squamous cell carcinoma (ESCC) is a highly aggressive cancer with a poor prognosis and limited treatment options. The role of ferroptosis, a regulated form of cell death, in tumor progression and immune regulation is being investigated.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
Four ferroptosis-related genes (CBS, CDCA3, GALNT14, IDO1) were identified for a prognostic model.
The model effectively stratified patients into high- and low-risk groups with significant differences in survival and immune infiltration.
CDCA3 knockdown inhibited proliferation and migration of ESCC cells and induced ferroptosis.
Single-cell sequencing confirmed upregulation of the identified genes in tumor cells.
Knockdown of CDCA3 led to changes in the expression of ferroptosis-related genes, enhancing sensitivity to the inducer RSL3.
Clinical Implications
Further exploration of ferroptosis-targeted therapies is warranted in this aggressive cancer type.
Conclusion
This study presents a robust ferroptosis gene signature with significant prognostic implications for ESCC, validated in clinical samples.
